259 related articles for article (PubMed ID: 18345966)
1. Escitalopram in the treatment of obsessive-compulsive disorder.
Zohar J
Expert Rev Neurother; 2008 Mar; 8(3):339-49. PubMed ID: 18345966
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
3. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
Hollander E; Stein DJ; Fineberg NA; Marteau F; Legault M
J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram prevents relapse of obsessive-compulsive disorder.
Fineberg NA; Tonnoir B; Lemming O; Stein DJ
Eur Neuropsychopharmacol; 2007; 17(6-7):430-9. PubMed ID: 17240120
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study.
Stryjer R; Dambinsky Y; Timinsky I; Green T; Kotler M; Weizman A; Spivak B
Int Clin Psychopharmacol; 2013 Mar; 28(2):96-8. PubMed ID: 23211492
[TBL] [Abstract][Full Text] [Related]
6. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
Pallanti S; Quercioli L; Koran LM
J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
[TBL] [Abstract][Full Text] [Related]
7. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy.
Stein DJ; Carey PD; Lochner C; Seedat S; Fineberg N; Andersen EW
CNS Spectr; 2008 Jun; 13(6):492-8. PubMed ID: 18567973
[TBL] [Abstract][Full Text] [Related]
9. Citalopram for treatment-resistant obsessive-compulsive disorder.
Pallanti S; Quercioli L; Paiva RS; Koran LM
Eur Psychiatry; 1999 Apr; 14(2):101-6. PubMed ID: 10572334
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram in the treatment of obsessive-compulsive disorder: a double blind placebo control trial.
Khan MN; Hotiana UA; Ahmad S
J Ayub Med Coll Abbottabad; 2007; 19(4):58-63. PubMed ID: 18693600
[TBL] [Abstract][Full Text] [Related]
11. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase.
Dell'Osso B; Hadley S; Allen A; Baker B; Chaplin WF; Hollander E
J Clin Psychiatry; 2008 Mar; 69(3):452-6. PubMed ID: 18312057
[TBL] [Abstract][Full Text] [Related]
12. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
[TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive disorder: an open-label pilot trial of escitalopram.
Galvão-de Almeida A; Quarantini LC; Góis CR; Santos-Jesus R; Miranda-Scippa AM; de Oliveira IR; da Silva Prado H; Leckman JF; Rosário MC
CNS Spectr; 2007 Jul; 12(7):519-24. PubMed ID: 17603402
[TBL] [Abstract][Full Text] [Related]
14. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
Pallanti S; Quercioli L; Bruscoli M
J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
Alaghband-Rad J; Hakimshooshtary M
Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
[TBL] [Abstract][Full Text] [Related]
16. Citalopram in refractory obsessive-compulsive disorder: an open study.
Marazziti D; Dell'Osso L; Gemignani A; Ciapparelli A; Presta S; Nasso ED; Pfanner C; Cassano GB
Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.
Stein DJ; Andersen EW; Tonnoir B; Fineberg N
Curr Med Res Opin; 2007 Apr; 23(4):701-11. PubMed ID: 17407626
[TBL] [Abstract][Full Text] [Related]
18. Comparing escitaloipram with sertraline for obsessive and compulsive symptoms in patients with obsessive compulsive disorder: A comparative double blind clinical trial.
Mowla A; Modarresi F; Dastgheib SA
Asian J Psychiatr; 2018 Dec; 38():92-95. PubMed ID: 29158148
[TBL] [Abstract][Full Text] [Related]
19. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density.
Wolmarans de W; Brand L; Stein DJ; Harvey BH
Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
